Last Updated:2025/11/25
Sentence
臨床試験では、免疫調節作用を有するキメラ型モノクローナル抗体が、用量依存的な免疫調節効果と許容できる安全性プロファイルを示した。
Quizzes for review
In the clinical trial, clenoliximab demonstrated dose-dependent immunomodulatory effects with an acceptable safety profile.
See correct answer
In the clinical trial, clenoliximab demonstrated dose-dependent immunomodulatory effects with an acceptable safety profile.
音声機能が動作しない場合はこちらをご確認ください
Related words
Word Edit Setting
- Users who have edit permission for words - All Users
- Screen new word creation
- Screen word edits
- Screen word deletion
- Screen the creation of new headword that may be duplicates
- Screen changing entry name
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Sentence Edit Setting
- Users who have edit permission for sentences - All Users
- Screen sentence deletion
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
Quiz Edit Setting
- Users who have edit permission for quizzes - All Users
- Users authorized to vote on judging - Editor
- Number of votes required for decision - 1
